Physician profile
Matthew Harb
NPI 1144630161
$2,890.45
in general payments reported to CMS, 2019-2025
11 companies · $13.25 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $224 · 2021: $915 · 2022: $1,012 · 2023: $727 · 2025: $13.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carestream Health, INC. | $1,025.00 | 2021-2022 | |
| Stryker Corporation | $720.97 | 2021-2023 | Gamma |
| Zimmer Biomet Holdings, INC. | $326.74 | 2023 | Persona |
| Smith+Nephew, INC. | $213.24 | 2022-2023 | Anthology, Real Intelligence |
| Ortho Development Corporation | $181.89 | 2023 | |
| Depuy Synthes Sales INC. | $126.43 | 2020-2022 | |
| Medical Device Business Services, INC. | $120.83 | 2020 | |
| Xiros INC | $68.34 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $57.44 | 2023 | Zilretta, Exparel, Iovera |
| Baudax Bio INC. | $36.32 | 2021 | |
| Checkpoint Surgical, INC | $13.25 | 2025 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Harb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.